# Anti-inflammatory effects of nicotinamide mononucleotide (NMN) in human skeletal muscle after BFR-exercise

**Authors:** Dai-Lin Yang, Kuo-Ching Chao, Hui-Tai Yang, Kuei-Hung Chen, Luthfia Dewi, Giancarlo Condello, Mengxin Ye, Andrew Nicholls, Yu-Chieh Liao, Chih-Yang Huang, Chia-Hua Kuo

PMC · DOI: 10.1080/15502783.2026.2632284 · Journal of the International Society of Sports Nutrition · 2026-02-18

## TL;DR

NMN reduces inflammation in human muscle after BFR-exercise but may also hinder mitochondrial recovery.

## Contribution

This study is the first to show NMN's anti-inflammatory effects in human skeletal muscle post-exercise and its impact on mitochondrial transfer.

## Key findings

- NMN suppressed TNF-α and IL-10 mRNA increases after BFR-exercise.
- NMN delayed p21 mRNA rise and mitochondrial replenishment in muscle.
- Phagocytes carried more mitochondria than myofibers, forming a diffusion gradient.

## Abstract

β-Nicotinamide mononucleotide (NMN) inhibits acute inflammation in injured animal tissues.

We examined whether NMN supplementation attenuates inflammation induced by blood flow restriction-resistance exercise (BFR-exercise) in human skeletal muscle.

Eleven untrained men (22.8 ± 1.5 y) completed a randomized, placebo-controlled, counterbalanced crossover trial, receiving either Placebo or NMN (1200 mg/d) for 7 d, with a 3-week washout between conditions. Multiple muscle biopsies were obtained before and after BFR-exercise.

BFR-exercise-induced significant muscle necrosis at 0 h, which resolved within 24 h in both conditions. NMN supplementation suppressed exercise-induced increases in TNF-α and IL-10 mRNA but delayed the rise in p21 mRNA, suggesting attenuated inflammatory signaling and delayed myogenic differentiation. The resolution of infiltrating cells from necrotic regions was moderately delayed by NMN. BFR-exercise increased the mitochondrial content in exercised muscle by 171% after 24 h of recovery. However, this adaptation was abolished with NMN. Immunofluorescence staining with TOM20 and myeloperoxidase (MPO) revealed that infiltrating phagocytes carried substantially more mitochondria than myofiber cytoplasm, forming a diffusion gradient toward damaged regions of myofibers. This concentration difference between phagocytes and myofibers was further confirmed using COX4 immunostaining in biopsied muscle from an additional participant.

NMN supplementation, while inhibiting inflammatory signaling in exercised human skeletal muscle, may also suppress mitochondrial replenishment from phagocytes to repairing myofibers.

## Linked entities

- **Genes:** TNF (tumor necrosis factor) [NCBI Gene 7124], IL10 (interleukin 10) [NCBI Gene 3586], CDKN1A (cyclin dependent kinase inhibitor 1A) [NCBI Gene 1026], TOMM20 (translocase of outer mitochondrial membrane 20) [NCBI Gene 9804], COX4I1 (cytochrome c oxidase subunit 4I1) [NCBI Gene 1327], MPO (myeloperoxidase) [NCBI Gene 4353]
- **Chemicals:** nicotinamide mononucleotide (PubChem CID 14180), NMN (PubChem CID 14180)

## Full-text entities

- **Genes:** IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, RPE (ribulose-5-phosphate-3-epimerase) [NCBI Gene 6120] {aka RPE2-1}, TOMM20 (translocase of outer mitochondrial membrane 20) [NCBI Gene 9804] {aka MAS20, MOM19, TOM20}, CDKN2A (cyclin dependent kinase inhibitor 2A) [NCBI Gene 1029] {aka ARF, CAI2, CDK4I, CDKN2, CMM2, INK4}, RPP30 (ribonuclease P/MRP subunit p30) [NCBI Gene 10556] {aka TSG15}, MPO (myeloperoxidase) [NCBI Gene 4353], H3P16 (H3 histone pseudogene 16) [NCBI Gene 644914] {aka H3.6, H3F3AP6, p21}, COX4I1 (cytochrome c oxidase subunit 4I1) [NCBI Gene 1327] {aka COX IV-1, COX4, COX4-1, COXIV, COXIV-1, MC4DN16}
- **Diseases:** acute lung injury (MESH:D055371), muscle (MESH:D019042), Inflammation (MESH:D007249), ischemia (MESH:D007511), muscle hypertrophy (MESH:C536106), reperfusion injury (MESH:D015427), tissue damage (MESH:D017695), necrosis (MESH:D009336), allergies (MESH:D004342), muscle injury (MESH:D009135), inflammatory drug (MESH:D000081015)
- **Chemicals:** fat (MESH:D005223), ethanol (MESH:D000431), guanidine thiocyanate (MESH:C054436), water (MESH:D014867), carbohydrate (MESH:D002241), NMN (MESH:D009537), cornstarch (MESH:D013213), Hematoxylin (MESH:D006416), silica (MESH:D012822), H&amp;E (MESH:D006371), lidocaine hydrochloride (MESH:D008012), BFR (-), 4',6-diamidino-2-phenylindole (MESH:C007293), alcohol (MESH:D000438), NAD+ (MESH:D009243), eosin (MESH:D004801), paraformaldehyde (MESH:C003043), LPS (MESH:D008070), citrate (MESH:D019343), ATP (MESH:D000255)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Solanum lycopersicum (tomato, species) [taxon 4081], Persea americana (avocado, species) [taxon 3435], Brassica oleracea var. italica (asparagus broccoli, varietas) [taxon 36774]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12918316/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12918316/full.md

## References

44 references — full list in the complete paper: https://tomesphere.com/paper/PMC12918316/full.md

---
Source: https://tomesphere.com/paper/PMC12918316